Summary
On August 7, 2014, CVS Health Corporation (then CVS Caremark Corporation) announced the issuance and sale of $1.5 billion in aggregate principal amount of senior notes. This offering was divided into two tranches: $850 million of 2.250% senior notes due in 2019 and $650 million of 3.375% senior notes due in 2024. The company intended to use the net proceeds, which approximated $1.48 billion after deducting underwriter discounts and estimated expenses, for general corporate purposes. This debt issuance provides the company with additional capital, potentially for strategic initiatives, acquisitions, or to refinance existing debt, thereby bolstering its financial flexibility.
Key Highlights
- 1CVS Health (CVS) priced $1.5 billion in senior notes through an Underwriting Agreement dated August 7, 2014.
- 2The offering consisted of $850 million of 2.250% senior notes due August 12, 2019.
- 3The offering also included $650 million of 3.375% senior notes due August 12, 2024.
- 4Net proceeds from the sale are estimated to be approximately $1.48 billion.
- 5The notes were issued under the company's existing Registration Statement on Form S-3.
- 6The closing of the sale of these notes was scheduled for August 12, 2014.
- 7The proceeds are intended for general corporate purposes, offering financial flexibility.